The Cooper Companies, Inc. (NASDAQ:COO) to Post Q3 2025 Earnings of $1.07 Per Share, William Blair Forecasts

The Cooper Companies, Inc. (NASDAQ:COOFree Report) – Equities research analysts at William Blair raised their Q3 2025 earnings estimates for shares of Cooper Companies in a report issued on Wednesday, September 4th. William Blair analyst M. Kaczor now anticipates that the medical device company will post earnings per share of $1.07 for the quarter, up from their prior estimate of $1.02. The consensus estimate for Cooper Companies’ current full-year earnings is $3.66 per share.

Cooper Companies (NASDAQ:COOGet Free Report) last released its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.91 by $0.05. The business had revenue of $1 billion during the quarter, compared to analyst estimates of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The company’s quarterly revenue was up 7.8% on a year-over-year basis. During the same period last year, the business posted $0.84 earnings per share.

A number of other research analysts have also recently weighed in on COO. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Thursday, August 29th. Piper Sandler boosted their price target on shares of Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th. Jefferies Financial Group raised Cooper Companies from a “hold” rating to a “buy” rating and upped their price objective for the stock from $107.00 to $115.00 in a research report on Tuesday, July 16th. Wells Fargo & Company lifted their target price on Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a report on Thursday, August 29th. Finally, Robert W. Baird upped their price target on Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a report on Thursday, August 29th. Four analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to MarketBeat, Cooper Companies currently has a consensus rating of “Moderate Buy” and a consensus price target of $113.61.

Get Our Latest Stock Analysis on COO

Cooper Companies Stock Performance

NASDAQ COO opened at $106.59 on Friday. The company has a market cap of $21.22 billion, a P/E ratio of 62.70, a P/E/G ratio of 2.56 and a beta of 0.98. Cooper Companies has a 1-year low of $75.93 and a 1-year high of $107.82. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.14. The stock has a 50-day moving average of $93.30 and a two-hundred day moving average of $94.65.

Insider Transactions at Cooper Companies

In other news, CFO Brian G. Andrews sold 24,788 shares of the business’s stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the completion of the sale, the chief financial officer now owns 6,614 shares in the company, valued at approximately $700,422.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Cooper Companies news, CFO Brian G. Andrews sold 24,788 shares of the company’s stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $105.90, for a total value of $2,625,049.20. Following the completion of the transaction, the chief financial officer now owns 6,614 shares in the company, valued at $700,422.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Daniel G. Mcbride sold 114,992 shares of Cooper Companies stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the sale, the chief operating officer now owns 44,696 shares in the company, valued at approximately $4,714,534.08. The disclosure for this sale can be found here. Corporate insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Cooper Companies

Large investors have recently modified their holdings of the company. Treasurer of the State of North Carolina raised its position in Cooper Companies by 0.9% in the 4th quarter. Treasurer of the State of North Carolina now owns 22,861 shares of the medical device company’s stock valued at $8,652,000 after purchasing an additional 212 shares during the last quarter. Hsbc Holdings PLC boosted its stake in shares of Cooper Companies by 55.3% during the fourth quarter. Hsbc Holdings PLC now owns 87,718 shares of the medical device company’s stock worth $33,188,000 after buying an additional 31,234 shares during the period. Quantbot Technologies LP purchased a new position in shares of Cooper Companies during the first quarter worth about $2,211,000. Whittier Trust Co. increased its position in Cooper Companies by 298.9% in the 1st quarter. Whittier Trust Co. now owns 11,940 shares of the medical device company’s stock valued at $1,211,000 after acquiring an additional 8,947 shares during the period. Finally, Envestnet Portfolio Solutions Inc. raised its stake in Cooper Companies by 43.1% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 35,233 shares of the medical device company’s stock valued at $3,076,000 after acquiring an additional 10,616 shares during the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

About Cooper Companies

(Get Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Featured Articles

Earnings History and Estimates for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.